MeiraGTx Holdings (MGTX) Operating Income (2017 - 2025)
MeiraGTx Holdings posted quarterly Operating Income of $26.5 million for Q4 2025, up 184.06% year-on-year from $9.3 million in Q4 2024, and up 157.48% on a QoQ basis from -$46.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Operating Income data on file, last reported at $26.5 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Income rose 184.06% year-over-year to $26.5 million; the trailing twelve-month figure through Dec 2025 stood at -$106.0 million (up 35.47% YoY), and the FY2025 full-year result was -$106.0 million, up 35.47% from the prior year.
- Operating Income for Q4 2025 stood at $26.5 million, up from -$46.1 million in the prior quarter.
- Across five years, Operating Income topped out at $26.5 million in Q4 2025 and bottomed at -$46.8 million in Q1 2024.
- The 5-year median for Operating Income is -$31.6 million (2023), against an average of -$29.8 million.
- The widest annual swing landed in 2022, when Operating Income slumped 433.88%; it then jumped 184.06% in 2025.
- A 5-year view of Operating Income shows it stood at -$7.7 million in 2021, then plunged by 433.88% to -$41.1 million in 2022, then slipped by 6.57% to -$43.8 million in 2023, then gained by 28.03% to -$31.5 million in 2024, then surged by 184.06% to $26.5 million in 2025.
- The last three Operating Income figures came in at $26.5 million (Q4 2025), -$46.1 million (Q3 2025), and -$44.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 26.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.47 Mn |
| Sep 30, 2025 | -46.05 Mn |
| Jun 30, 2025 | -44.79 Mn |
| Mar 31, 2025 | -41.60 Mn |
| Dec 31, 2024 | -31.49 Mn |
| Sep 30, 2024 | -40.04 Mn |
| Jun 30, 2024 | -45.91 Mn |
| Mar 31, 2024 | -46.77 Mn |
| Dec 31, 2023 | -43.75 Mn |
| Sep 30, 2023 | -32.76 Mn |
| Jun 30, 2023 | -28.79 Mn |
| Mar 31, 2023 | -31.76 Mn |
| Dec 31, 2022 | -41.06 Mn |
| Sep 30, 2022 | -22.81 Mn |
| Jun 30, 2022 | -23.76 Mn |
| Mar 31, 2022 | -28.73 Mn |
| Dec 31, 2021 | -7.69 Mn |
| Sep 30, 2021 | -22.55 Mn |
| Jun 30, 2021 | -20.48 Mn |
| Mar 31, 2021 | -22.03 Mn |
| Dec 31, 2020 | -13.22 Mn |
| Sep 30, 2020 | -8.43 Mn |
| Jun 30, 2020 | -25.23 Mn |
| Mar 31, 2020 | -15.68 Mn |
| Dec 31, 2019 | -5.44 Mn |
| Sep 30, 2019 | -10.91 Mn |
| Jun 30, 2019 | -21.23 Mn |
| Mar 31, 2019 | -20.69 Mn |
| Dec 31, 2018 | -20.15 Mn |
| Sep 30, 2018 | -14.74 Mn |
| Jun 30, 2018 | -25.17 Mn |
| Mar 31, 2018 | -18.05 Mn |
| Dec 31, 2017 | 17.34 Mn |
| Sep 30, 2017 | -8.76 Mn |
| Jun 30, 2017 | -7.59 Mn |